OTC Markets OTCQB - Delayed Quote USD

IDenta Corp. (IDTA)

0.5600
0.0000
(0.00%)
At close: May 23 at 4:00:00 PM EDT
Loading Chart for IDTA
  • Previous Close 0.0000
  • Open 0.5600
  • Bid 0.2622 x --
  • Ask 0.4999 x 40000
  • Day's Range 0.5600 - 0.5600
  • 52 Week Range 0.2740 - 0.8900
  • Volume 250
  • Avg. Volume 1,150
  • Market Cap (intraday) 2.266M
  • Beta (5Y Monthly) 2.88
  • PE Ratio (TTM) 5.60
  • EPS (TTM) 0.1000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

IDenta Corp. operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company has operations in Israel, the United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Nigeria, Canada, and internationally. IDenta Corp. was founded in 2002 and is headquartered in Jerusalem, Israel.

www.identa-corp.com

11

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IDTA

View More

Performance Overview: IDTA

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IDTA
49.73%
S&P 500 (^GSPC)
1.34%

1-Year Return

IDTA
30.84%
S&P 500 (^GSPC)
10.16%

3-Year Return

IDTA
1.82%
S&P 500 (^GSPC)
46.03%

5-Year Return

IDTA
270.86%
S&P 500 (^GSPC)
96.34%

Compare To: IDTA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IDTA

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    2.27M

  • Enterprise Value

    2.53M

  • Trailing P/E

    5.44

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.63

  • Price/Book (mrq)

    3.40

  • Enterprise Value/Revenue

    1.57

  • Enterprise Value/EBITDA

    4.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.14%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.2M

  • Net Income Avi to Common (ttm)

    25.75k

  • Diluted EPS (ttm)

    0.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    678.34k

  • Total Debt/Equity (mrq)

    91.98%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: IDTA

View More

Company Insights: IDTA

Research Reports: IDTA

View More

People Also Watch